Abcam Antibodies Validated for CUT&RUN featuring EpiCypher
Abcam and EpiCypher have partnered to set a higher standard for antibody validation in CUT&RUN. By uniting Abcam’s deep recombinant antibody expertise with EpiCypher’s advanced chromatin profiling innovation, this collaboration delivers robust CUT&RUN antibodies validated to meet the demands of modern gene regulation research; where specificity, reproducibility, and biological accuracy define experimental success.
